Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.2% |
| 2 | Technology | 14.19% |
| 3 | Financials | 12.33% |
| 4 | Consumer Staples | 10.22% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Hyatt Hotels
H
$17.1B
| $3.29M | ﹤0.01% |
58,500
-30,500
| -34% | -$1.73M |
|
1977
Intrepid Potash
IPI
$493M
| $3.29M | ﹤0.01% |
145,420
-152,330
| -51% | -$3.19M |
|
|
WFT
1978
DELISTED
Weatherford International plc
WFT
| $3.29M | ﹤0.01% |
848,745
-5,600,485
| -87% | -$28.5M |
|
1979
Lennar Class B
LEN.B
$20.6B
| $3.26M | ﹤0.01% |
77,688
+4,614
| +6% | +$187K |
|
1980
STRATTEC Security
STRT
$348M
| $3.25M | ﹤0.01% |
91,865
-9,756
| -10% | -$307K |
|
|
BPY
1981
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $3.25M | ﹤0.01% |
137,214
-308,184
| -69% | -$6.96M |
|
1982
Century Communities
CCS
$2.01B
| $3.25M | ﹤0.01% |
130,900
-44,400
| -25% | -$1.15M |
|
|
PDS
1983
Precision Drilling
PDS
$1.09B
| $3.23M | ﹤0.01% |
47,413
-3,830
| -7% | -$297K |
|
1984
VSE Corp
VSEC
$6.79B
| $3.23M | ﹤0.01% |
71,900
-14,500
| -17% | -$620K |
|
|
PCOM
1985
DELISTED
Points.com Inc. Common Shares
PCOM
| $3.23M | ﹤0.01% |
357,600
+2,900
| +0.8% | +$26.6K |
|
1986
NatWest
NWG
$76B
| $3.23M | ﹤0.01% |
+459,364
| New | +$3.21M |
|
|
TOUR
1987
Tuniu
TOUR
$53.2M
| $3.23M | ﹤0.01% |
40,200
+31,740
| +375% | +$2.61M |
|
1988
Myers Industries
MYE
$1.24B
| $3.23M | ﹤0.01% |
179,800
+57,700
| +47% | +$990K |
|
|
PTX
1989
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $3.22M | ﹤0.01% |
800,050
+59,400
| +8% | +$259K |
|
1990
United-Guardian
UG
$32.8M
| $3.19M | ﹤0.01% |
206,400
+2,500
| +1% | +$37.2K |
|
|
HDNG
1991
DELISTED
Hardinge Inc
HDNG
| $3.19M | ﹤0.01% |
256,800
+34,097
| +15% | +$393K |
|
|
KTWO
1992
DELISTED
K2M Group Holdings, Inc
KTWO
| $3.19M | ﹤0.01% |
130,772
-21,868
| -14% | -$486K |
|
|
DL
1993
DELISTED
China Distance Education Holdings Limited
DL
| $3.18M | ﹤0.01% |
356,000
-25,503
| -7% | -$252K |
|
1994
Mannatech
MTEX
$12.1M
| $3.17M | ﹤0.01% |
203,460
+1,500
| +0.7% | +$22.5K |
|
1995
KT
KT
$9.11B
| $3.17M | ﹤0.01% |
+190,500
| New | +$3.11M |
|
|
VTTI
1996
DELISTED
VTTI Energy Partners LP
VTTI
| $3.15M | ﹤0.01% |
160,513
+52,510
| +49% | +$1.01M |
|
1997
KLA
KLAC
$266B
| $3.15M | ﹤0.01% |
+344,000
| New | +$3.43M |
|
|
LL
1998
DELISTED
LL Flooring Holdings, Inc.
LL
| $3.15M | ﹤0.01% |
125,500
-176,500
| -58% | -$4.43M |
|
1999
Northeast Bank
NBN
$1.15B
| $3.14M | ﹤0.01% |
154,308
+60,308
| +64% | +$1.1M |
|
|
ITIC
2000
Investors Title Co
ITIC
$543M
| $3.13M | ﹤0.01% |
16,200
+500
| +3% | +$90.7K |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.